195 related articles for article (PubMed ID: 12452466)
1. Cost effectiveness of pre-operative gonadotrophin releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy.
Farquhar C; Brown PM; Furness S
BJOG; 2002 Nov; 109(11):1273-80. PubMed ID: 12452466
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review.
Lethaby A; Vollenhoven B; Sowter M
BJOG; 2002 Oct; 109(10):1097-108. PubMed ID: 12387461
[TBL] [Abstract][Full Text] [Related]
3. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
[TBL] [Abstract][Full Text] [Related]
4. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of pre-operative gonadotrophin releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy.
Sharma M; Buck L; Mastrogamvrakis G; Kontos K; Magos A; Taylor A
BJOG; 2003 Jul; 110(7):712; author reply 712-3. PubMed ID: 12842071
[No Abstract] [Full Text] [Related]
6. Preoperative medical therapy before surgery for uterine fibroids.
Lethaby A; Puscasiu L; Vollenhoven B
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD000547. PubMed ID: 29139105
[TBL] [Abstract][Full Text] [Related]
7. Hysterectomy and myomectomy by laparotomy.
West CP
Baillieres Clin Obstet Gynaecol; 1998 Jun; 12(2):317-35. PubMed ID: 10023424
[TBL] [Abstract][Full Text] [Related]
8. Uterine artery embolization, hysterectomy, or myomectomy for symptomatic uterine fibroids: a cost-utility analysis.
You JH; Sahota DS; Yuen PM
Fertil Steril; 2009 Feb; 91(2):580-8. PubMed ID: 18295216
[TBL] [Abstract][Full Text] [Related]
9. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
10. Traditional surgical approaches to uterine fibroids: abdominal myomectomy and hysterectomy.
Guarnaccia MM; Rein MS
Clin Obstet Gynecol; 2001 Jun; 44(2):385-400. PubMed ID: 11345000
[TBL] [Abstract][Full Text] [Related]
11. Cost and reimbursement for three fibroid treatments: abdominal hysterectomy, abdominal myomectomy, and uterine fibroid embolization.
Goldberg J; Bussard A; McNeil J; Diamond J
Cardiovasc Intervent Radiol; 2007; 30(1):54-8. PubMed ID: 17031734
[TBL] [Abstract][Full Text] [Related]
12. The management of uterine leiomyomas.
Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
[TBL] [Abstract][Full Text] [Related]
13. Ulipristal acetate for pre-operative management of uterine fibroids: Modeling outcomes and costs.
Badiani B; Chiumente M; Messori A
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():84-88. PubMed ID: 29408752
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) for Treatment of Symptomatic Uterine Fibroids: An Economic Analysis.
Babashov V; Palimaka S; Blackhouse G; O'Reilly D
Ont Health Technol Assess Ser; 2015; 15(5):1-61. PubMed ID: 26357531
[TBL] [Abstract][Full Text] [Related]
15. The impact of preoperative gonadotropin-releasing hormone agonist treatment on women with uterine fibroids: a meta-analysis.
Zhang Y; Sun L; Guo Y; Cheng J; Wang Y; Fan S; Duan H
Obstet Gynecol Surv; 2014 Feb; 69(2):100-8. PubMed ID: 25112488
[TBL] [Abstract][Full Text] [Related]
16. Uterine artery embolisation or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: a cost-utility analysis of the FEMME trial.
Rana D; Wu O; Cheed V; Middleton LJ; Moss J; Lumsden MA; McKinnon W; Daniels J; Sirkeci F; Manyonda I; Belli AM; McPherson K;
BJOG; 2021 Oct; 128(11):1793-1802. PubMed ID: 34053154
[TBL] [Abstract][Full Text] [Related]
17. GnRH agonists before surgery for uterine leiomyomas. A review.
Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
[TBL] [Abstract][Full Text] [Related]
18. The cost-effectiveness of ulipristal acetate tablets in treating patients with moderate to severe symptoms of uterine fibroids.
Nagy B; Timár G; Józwiak-Hagymásy J; Kovács G; Merész G; Vámossy I; Ágh T; László Á; Vokó Z; Kaló Z
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():75-81. PubMed ID: 24568866
[TBL] [Abstract][Full Text] [Related]
19. Potential cost savings using GnRH agonists as preoperative therapy for uterine leiomyomas.
Saltiel E
Formulary; 1995 Sep; 30(9):532-4, 542. PubMed ID: 10161243
[TBL] [Abstract][Full Text] [Related]
20. GnRH agonist therapy before myomectomy or hysterectomy.
Gutmann JN; Corson SL
J Minim Invasive Gynecol; 2005; 12(6):529-37; quiz 528, 538-9. PubMed ID: 16337584
[No Abstract] [Full Text] [Related]
[Next] [New Search]
